camptothecin has been researched along with Sarcoma 180 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, BC; Chen, J; Chen, ZP; Fang, F; Gong, F; Gu, W; Hu, RR; Luo, L; Tian, R; Yang, XX | 1 |
| Dong, J; Fu, Y; Gong, T; Lian, X; Lin, Q; Teng, Y; Zhang, J | 1 |
| Hong, M; Jiang, Y; Pei, Y; Tang, G; Zhu, S | 1 |
| Fang, C; Hong, M; Jiang, Y; Pei, Y; Shi, B; Sun, C; Tang, G; Zhu, S | 1 |
| Chen, JH; Lai, CL; Lai, L; Zhao, JB | 1 |
| Chen, Y; Fang, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Sha, X; Xin, H; Zhang, W | 1 |
| Akagi, T; Higuchi, S; Inoue, K; Ishizaki, T; Kage, Y; Makinosumi, T; Ohdo, S; Taguchi, Y; Ushinohama, K; Yamauchi, A; Yukawa, E | 1 |
| Machida, Y; Onishi, H | 1 |
| Luan, LB; Wei, KB; Yu, WP; Zhu, JB | 1 |
| Machida, Y; Miura, H; Onishi, H; Sasatsu, M | 1 |
| Chen, Y; Ding, J; Gao, H; Li, C; Lu, W; Pang, T; Shen, H; Sun, J; Xu, C; Zhang, X | 1 |
| Kunii, R; Machida, Y; Onishi, H | 1 |
| Chang, GT; Ding, JD; Yu, L; Zhang, H | 1 |
| Koyama, K; Kunii, R; Machida, Y; Onishi, H; Ueki, K | 1 |
| Abe, H; Fujita, H; Ishii, R; Okamoto, M; Takao, A; Takeda, K | 1 |
| Abe, H; Arase, H; Fujita, H; Ishii, R; Okamoto, M; Takao, A | 1 |
| Liu, J; Xu, B; Zhou, JJ | 1 |
17 other study(ies) available for camptothecin and Sarcoma 180
| Article | Year |
|---|---|
Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Camptothecin; Hydrogen-Ion Concentration; Injections, Intravenous; Lactones; Mice; Mice, Inbred ICR; Sarcoma 180; Tissue Distribution; Toxicity Tests | 2013 |
Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Transport; Caco-2 Cells; Camptothecin; Cell Culture Techniques; Drug Carriers; Drug Compounding; Endocytosis; Gastrointestinal Tract; Humans; Male; Mice, Inbred ICR; Molecular Structure; Particle Size; Polyethylene Glycols; Polyvinyls; Rats, Sprague-Dawley; Sarcoma 180; Surface Properties | 2014 |
Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Topics: Animals; Antineoplastic Agents; Biological Availability; Camptothecin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cyanoacrylates; Cytoplasm; Drug Delivery Systems; Endocytosis; Humans; K562 Cells; Liposomes; Male; Mice; Mice, Inbred Strains; Neoplasms; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Sarcoma 180; Tissue Distribution; Transferrin | 2009 |
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Humans; Male; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Sarcoma 180; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tissue Distribution; Transferrin; Xenograft Model Antitumor Assays | 2010 |
[Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cyclodextrins; Drug Carriers; Drug Compounding; Female; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Ovarian Neoplasms; Poloxamer; Rotaxanes; Sarcoma 180; Tumor Burden | 2010 |
Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Sarcoma 180; Toxicity Tests, Chronic; Xenograft Model Antitumor Assays | 2011 |
Cell kinetics-dependent antitumor effect of irinotecan hydrochloride induced by the synchronizing effect of hydroxyurea: cell kinetics and dosing time.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Body Weight; Bone Marrow Cells; Camptothecin; Cell Cycle; DNA; Esterases; Hydroxyurea; Irinotecan; Male; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Sarcoma 180 | 2003 |
Antitumor properties of irinotecan-containing nanoparticles prepared using poly(DL-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol).
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Dosage Forms; Growth Inhibitors; Irinotecan; Lactates; Male; Mice; Microspheres; Nanotechnology; Polyethylene Glycols; Rats; Rats, Wistar; Sarcoma 180; Xenograft Model Antitumor Assays | 2003 |
[Studies on the preparation of camptothecin niosomes].
Topics: Acrylic Resins; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cholesterol; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Mice; Neoplasm Transplantation; Particle Size; Sarcoma 180; Surface-Active Agents; Tumor Cells, Cultured | 2002 |
Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin.
Topics: Animals; Antineoplastic Agents; Camptothecin; Lactic Acid; Male; Mice; Nanostructures; Polyethylene Glycols; Rats; Rats, Wistar; Sarcoma 180 | 2004 |
Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Stability; Enzyme Inhibitors; Humans; Mice; Sarcoma 180; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2005 |
Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.
Topics: Algorithms; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Camptothecin; Chromatography, High Pressure Liquid; Excipients; Injections, Intravenous; Lactic Acid; Male; Mice; Nanoparticles; Neoplasm Transplantation; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Sarcoma 180 | 2007 |
Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Camptothecin; Delayed-Action Preparations; Drug Delivery Systems; Glycolates; Hydrogels; Injections, Subcutaneous; Kinetics; Lactic Acid; Mice; Mice, Inbred Strains; Microscopy, Electron, Transmission; Phase Transition; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sarcoma 180; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Transition Temperature; Viscosity | 2008 |
Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Hydrogen-Ion Concentration; Lactic Acid; Male; Mice; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Propylene Glycols; Sarcoma 180; Solubility; Tissue Distribution | 2008 |
[Pharmacokinetics of SK & F 104864 in experimental animals. I. Plasma level].
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Half-Life; Infusions, Intravenous; Male; Mice; Mice, Inbred ICR; Rabbits; Sarcoma 180; Topotecan | 1995 |
[Pharmacokinetics of SK & F 104864 in experimental animals. II. Tissue distribution].
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Injections, Intravenous; Mice; Mice, Inbred ICR; Sarcoma 180; Tissue Distribution; Topotecan | 1995 |
Relationship between lactone ring forms of HCPT and their antitumor activities.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Female; Humans; Lactones; Liver Neoplasms; Mice; Sarcoma 180; Tumor Cells, Cultured | 2001 |